Han Yi, Jiang Lu, Shi Huihui, Xu Chenfang, Liu Minting, Li Qingjian, Zheng Lan, Chi Hong, Wang Mingyue, Liu Zuguo, You Mingliang, Loh Xian Jun, Wu Yun-Long, Li Zibiao, Li Cheng
Fujian Provincial Key Laboratory of Ophthalmology and Visual Science & Ocular Surface and Corneal Diseases, Eye Institute & Affiliated Xiamen Eye Center, School of Medicine, Xiamen University, Xiamen, 361102, China.
Institute of Materials Research and Engineering, ASTAR (Agency for Science, Technology and Research), Singapore, 138634, Singapore.
Bioact Mater. 2021 Jul 28;9:77-91. doi: 10.1016/j.bioactmat.2021.07.027. eCollection 2022 Mar.
Dry eye is a common ocular disease that results in discomfort and impaired vision, impacting an individual's quality of life. A great number of drugs administered in eye drops to treat dry eye are poorly soluble in water and are rapidly eliminated from the ocular surface, which limits their therapeutic effects. Therefore, it is imperative to design a novel drug delivery system that not only improves the water solubility of the drug but also prolongs its retention time on the ocular surface. Herein, we develop a copolymer from mono-functional POSS, PEG, and PPG (MPOSS-PEG-PPG, MPEP) that exhibits temperature-sensitive sol-gel transition behavior. This thermo-responsive hydrogel improves the water solubility of FK506 and simultaneously provides a mucoadhesive, long-acting ocular delivery system. In addition, the FK506-loaded POSS hydrogel possesses good biocompatibility and significantly improves adhesion to the ocular surface. In comparison with other FK506 formulations and the PEG-PPG-FK506 (F127-FK506) hydrogel, this novel MPOSS-PEG-PPG-FK506 (MPEP-FK506) hydrogel is a more effective treatment of dry eye in the murine dry eye model. Therefore, delivery of FK506 in this POSS hydrogel has the potential to prolong drug retention time on the ocular surface, which will improve its therapeutic efficacy in the management of dry eye.
干眼症是一种常见的眼部疾病,会导致不适和视力受损,影响个人生活质量。大量用于治疗干眼症的眼药水药物在水中溶解度低,且会迅速从眼表清除,这限制了它们的治疗效果。因此,设计一种新型药物递送系统势在必行,该系统不仅要提高药物的水溶性,还要延长其在眼表的保留时间。在此,我们由单官能团倍半硅氧烷(POSS)、聚乙二醇(PEG)和聚丙二醇(PPG)合成了一种共聚物(MPOSS-PEG-PPG,MPEP),它具有温度敏感的溶胶-凝胶转变行为。这种热响应水凝胶提高了FK506的水溶性,同时提供了一种具有粘膜粘附性的长效眼部递送系统。此外,负载FK506的POSS水凝胶具有良好的生物相容性,并显著提高了对眼表的粘附性。与其他FK506制剂和PEG-PPG-FK506(F127-FK506)水凝胶相比,这种新型的MPOSS-PEG-PPG-FK506(MPEP-FK506)水凝胶在小鼠干眼症模型中对干眼症的治疗更有效。因此,在这种POSS水凝胶中递送FK506有可能延长药物在眼表的保留时间,这将提高其在干眼症治疗中的疗效。